DelSiTech
Business Services · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
C Itäinen Pitkäkatu 4, Turku, Southwest ...Phone Number
+358 22510110Website
www.delsitech.comRevenue
<$5 MillionIndustry
About DelSiTech
Is DelSiTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at DelSiTech
Product Launch: Get notified when DelSiTech launches new products
Earning: See what the market has to say on DelSiTech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if DelSiTech is spiking on competitors!
Check if DelSiTech has recently received funding, and reach out quickly before it becomes old news!
Click to see if DelSiTech had a recent Job posting/layoffs
DelSiTech, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once DelSiTech has new funding data
Recommended Actions
Reach out to Masked Content who joined DelSiTech as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
DelSiTech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DelSiTech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DelSiTech.
DelSiTech financials insights
Gather financial insights about DelSiTech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Other Financing Round
$10.8M
DelSiTech Tech Stack
A closer look at the technologies used by DelSiTech
DelSiTech News & Media
DelSiTech and Tolmar Announce Global License and Development Agreement
Tolmar secures global license to DelSiTech's Silica Matrix technology to develop and commercialize two undisclosed drug targets DelSiTech and Tolmar to expand development of additional drug products across a range of therapeutic areas DelSiTech is eligible to receive upfront payments,...DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
New investment from DRW Venture Capital LLC and Tolmar International Ltd Funds will be used to advance its proprietary, silica-based, drug delivery technology platform towards the clinic and further build DelSiTech TURKU, Finland, Jan. 16, 2024 /PRNewswire/ -- Clinical-stage drug delivery...DelSiTech announces positive topline clinical data from phase 1 trial with its sustained release eye drop platform
TURKU, Finland, June 29, 2023 /PRNewswire/ -- Drug delivery and development company DelSiTech today reported positive topline results from its Phase 1 clinical trial, evaluating the safety and tolerability of DST-2105, DelSiTech's first of its kind, silica-based, long-acting demulcent eye...Bill Gates's March Venture Investments: Biotech, Energy, And Taking On Methane Emissions
Microsoft Corp. Founder Bill Gates is known as an all-around smart guy, but he’s a man of many hats. See More: A Healthier Alternative to Coffee & Energy Drinks: Pureboost Gives You Energy Without The Burnout and Exhaustion Gates is also an astute investor with diverse holdings in numerous sectors. As you might imagine, one of Gates’s favorite investments is tech startups, and he made some interesting moves in March. Benzinga takes a look at
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DelSiTech
DelSiTech is a technology platform company that specializes in long-acting formulations aimed at transforming treatment for metabolic diseases and pain. Utilizing its proprietary Silica Matrix technology, DelSiTech develops biodegradable drug delivery systems compatible with various therapeutic agents, providing long-lasting treatment options. The... Read More